For decades, scientists were baffled by why thorny skates in the North Atlantic came in two distinct sizes. Despite extensive ...
In a nutshell All modern humans share DNA from two ancient populations that split 1.5 million years ago and reunited through ...
Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim readout expected in the second half of 2025 —U.S. Food and ...
Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...
With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses the multifunctionality of the natural ...
The global electrophoresis market size was $2.3 billion in 2021, and is projected to reach $4 billion by 2031, growing at a CAGR of 5.7% from 2022 to ...
Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to the biopharmceutical company Benitec Biopharma (BNTC) . I found the stock by ...
Using single-cell RNA sequencing, we mapped thousands of expression quantitative trait loci in yeast, including a variant in GPA1 that influences gene expression, cell-cycle occupancy, and mating ...
A total of 125 paired human HCC and adjacent NT tissues that were surgically removed, snap frozen in liquid nitrogen (for protein, RNA and DNA extraction) and embedded in a paraffin block (for tissue ...
The Stock Price Chart contained here is smoothed, and does not include any of the technical indicators that we offer our subscribers. Price action tells us where to buy and sell, and this information ...
Wells Fargo analyst Yanan Zhu maintained a Buy rating on Avidity Biosciences (RNA – Research Report) on February 28 and set a price target of $70.00. The company’s shares closed last Friday at ...
In a report released today, Gena Wang from Barclays maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a price target of $57.00. The company’s shares closed yesterday ...